Products

Quisqualis Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Quisqualis Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: quisqualis-fructus-veterinary-grade-api-for-tablets-injections-capsules-powders-granules-premix-solutions
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    680025

    Product Name Quisqualis Fructus Veterinary Grade API
    Dosage Forms Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions
    Active Ingredient Quisqualis Fructus extract
    Application Veterinary use
    Appearance Fine powder or granulated extract
    Solubility Water-soluble
    Purity >98%
    Shelf Life 24 months
    Storage Conditions Store in a cool, dry place, away from direct sunlight
    Packaging Sealed drum or bag, customizable on request
    Country Of Origin China
    Intended Species Livestock, poultry, swine, companion animals
    Certificate GMP/Veterinary drug license available
    Usage Anthelmintic, digestive support, general tonic
    Color Brown to yellowish-brown

    As an accredited Quisqualis Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Sealed 25kg fiber drum with inner double-layer PE bags, labeled: "Quisqualis Fructus Veterinary Grade API – For Pharmaceuticals Use Only."
    Shipping The Quisqualis Fructus Veterinary Grade API is securely packaged in tamper-proof, moisture-resistant containers suitable for shipping. It is dispatched via certified carriers, ensuring safe, prompt delivery to maintain product integrity. Suitable for tablets, injections, capsules, powders, granules, premix, or solutions, with tracking and documentation provided for each shipment.
    Storage Store Quisqualis Fructus Veterinary Grade API in its original, tightly sealed container, protected from moisture, light, and direct heat. Maintain storage in a cool, dry place at temperatures below 25°C (77°F). Keep away from incompatible substances and ensure good ventilation. Avoid contamination by sealing after each use. Follow local regulations and guidelines for chemical storage and handling.
    Application of Quisqualis Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Quisqualis Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    As the original manufacturer of veterinary-grade Quisqualis Fructus API, we exclusively support integration into high-volume animal health production lines. Our material aligns with evolving global standards and addresses genuine market demand in advanced livestock, companion animal, and aquatic health product formulations. The following sections provide detailed industrial use cases, standardized compliance benchmarks, precise formulation guidelines, integration processes, and downstream product categories, ensuring our partners achieve traceable, regulatory-compliant finished goods.

    1. Livestock Oral Tablet Production

    Livestock oral solid dose manufacturing adopts Quisqualis Fructus API for formulating chewable and coated tablets targeting gastrointestinal wellness and immune system support in ruminants and swine. Formulators focus on maximizing bioavailability while adhering to region-specific residue limits and excipient compatibility, with strict concentration monitoring in final tablets to prevent overage and maintain label accuracy throughout commercial batch release processes.

    Industry compliance standards

    • China Veterinary Pharmacopoeia (2020 Edition, Section IV—Herbal Preparations)
    • European Pharmacopoeia (Ph. Eur.) Monographs for Herbal Veterinary APIs
    • FDA GFI#209, GFI#213 (US extralabel restrictions)
    • Good Manufacturing Practice (GMP) for Veterinary Medicinal Products (EU GMP Volume 4, WHO GMP)

    Typical usage ratio

    • 1.5%–4% w/w of total tablet mass; adjusted by species, target claim, and regulatory allowed actives per dose format

    Downstream process integration

    • Blending with diluents, binders, and lubricants after initial milling; direct compression or wet granulation; granule sizing and tablet pressing followed by coating or polishing step

    Final product types

    • Cattle and swine chewable gastrointestinal-support tablets
    • Calf and sheep multi-herb immune health tablets
    • Anthelmintic targeted combination tablets

    2. Injectable Veterinary Solution Manufacturing

    Sterile injectable solutions for veterinary use introduce Quisqualis Fructus API as an active botanical compound for subcutaneous or intramuscular administration, predominantly in high-value livestock where rapid systemic absorption is prioritized. Manufacturers emphasize solvent compatibility, particle minimization, and residue validation to deliver quality-assured lots that align with medication controls and animal treatment protocols in regulated markets.

    Industry compliance standards

    • United States Pharmacopoeia (USP 41, Chapter <797>—Compounding Sterile Preparations)
    • China Veterinary Drug GMP (2019 Revision, Sterile Sterilization Processes)
    • Commission Regulation (EU) 2019/6 on Veterinary Medicinal Products
    • ICH Q7 for Active Pharmaceutical Ingredients

    Typical usage ratio

    • 0.1%–1.2% w/v depending on solvent system, carrier compatibility, and target intramuscular dose per animal

    Downstream process integration

    • API dissolved or suspended post-filtration in sterile vehicle; compounded under laminar flow conditions; sterile filtration; aseptic vial or ampoule filling and terminal sterilization in accordance with validated SOPs

    Final product types

    • Veterinary injectable anti-inflammatory solutions for cattle and equine
    • Combined anti-parasitic injectable formulations
    • Supportive care injectables for high-stress production animals

    3. Companion Animal Capsule and Granule Manufacturing

    In pet health manufacturing, Quisqualis Fructus API enters hard gelatin capsules and flavored granule blends, enhancing joint mobility, digestive comfort, and immune modulation for dogs and cats. The capsule-form process ensures controlled dispensing and stability, while granules facilitate taste masking and ease of administration in smaller companion animals, with attention to excipient compatibility and market label claims.

    Industry compliance standards

    • Association of American Feed Control Officials (AAFCO) Model Regulations for Animal Supplements
    • FDA 21 CFR Part 111 (Dietary Supplements, as interpreted for pets)
    • European Feed Additive Regulation (EC) No 1831/2003
    • ISO 9001:2015 certification for supplement manufacturing

    Typical usage ratio

    • 0.8%–2.5% in final capsule or granule weight; titrated for animal size, daily dosage targets, and palatability in composite blends

    Downstream process integration

    • API micronized, screened, then dry blended with carriers; capsule filling on automatic lines; or mixed with flavorants and binders for granulation, sifting, and pouch or jar packaging

    Final product types

    • Dog and cat immune-support capsules
    • Palatable soft granules for senior pet supplementation
    • Combination joint health capsules for large breeds

    4. Aquaculture Premix and Water-Soluble Powder Formulation

    Aquaculture feed additive manufacturers use Quisqualis Fructus API in premixed formulations and water-soluble powders for disease resistance and nutritional support in farmed fish and crustaceans. The focus remains on dispersibility in aquatic environments and stability under variable storage conditions, maintaining compliance with residue monitoring programs and maximizing intake through feed or water supplementation.

    Industry compliance standards

    • FAO Code of Practice for Fish and Fishery Products (CAC/RCP 52-2003)
    • China Ministry of Agriculture Veterinary Feed Additive Directory
    • European Feed Additives and Premixtures Quality System (FAMI-QS v6.0)
    • ISO 22000:2018 Food Safety Management for Feed

    Typical usage ratio

    • 0.2%–0.6% of total premix or water-soluble powder, adjusted by species, stocking density, and local regulatory thresholds for herbal actives

    Downstream process integration

    • API added to carrier matrix during premix blending; homogenized and milled to uniform particle size; sieved for water dispersion or direct dry feed mixing, followed by bulk or foil packaging

    Final product types

    • Aquaculture water-soluble immunity enhancers for shrimp and tilapia
    • Feed-grade herbal premix for high-density freshwater species
    • Anti-stress nutritional additives for marine cage aquaculture

    5. Multispecies Veterinary Oral Solution Blends

    For multispecies husbandry, manufacturers incorporate Quisqualis Fructus API in liquid oral solutions designed for poultry and small livestock, supporting flock-wide intervention strategies. The development emphasizes solubility enhancement, suspension stability, and ease of dosing via automated waterlines or trough systems, meeting requirements for rapid distribution across large animal populations.

    Industry compliance standards

    • OIE Terrestrial Code for Veterinary Products (Relevant Chapters for Medicated Solutions)
    • Japan Veterinary Drugs Control Act—Feed Additive Directives
    • ISO 22716:2007 (Good Manufacturing Practices for Animal Health Products)
    • GMP for Liquid Veterinary Medicines (China GMP 2020 Edition)

    Typical usage ratio

    • 0.3%–1.0% in solution concentrate, titrated based on delivery system type, ambient temperatures, dosing rate per animal, and regional dilution guidelines

    Downstream process integration

    • API dissolved or uniformly suspended in aqueous or oil-based phase; combined with flavorants, stabilizers, and preservatives; filtered, homogenized, and filled into HDPE bottles or bulk drums

    Final product types

    • Poultry oral herbal support solutions
    • Small ruminant gut health oral drench
    • Mixed-stock multi-pathogen management oral liquids

    6. Ruminant Medicated Feed Additive Granules

    Ruminant nutrition technology integrates Quisqualis Fructus API into medicated feed granules allowing precise delivery of herbal actives alongside major macro- and micro-nutrients. Feed manufacturers consider heat stability during pelletization, homogeneous API distribution, and adherence to residue limitations, with traceable production records throughout the blending and granulation cycles.

    Industry compliance standards

    • Codex Alimentarius Guidelines on Residues in Food (CAC/MRL 2-2015)
    • European Union Regulation (EC) 183/2005 on Feed Hygiene
    • China GB 13078-2017 (Hygienic Standards for Compound Feeds)
    • Good Manufacturing Practice for Feed Additives (FAMI-QS)

    Typical usage ratio

    • 0.3%–0.8% w/w, optimized for ruminant weight, intended feed intake rate, seasonality, and minimum withdrawal period requirements

    Downstream process integration

    • API blended with primary feed matrix; introduced just before granulation or extrusion to minimize degradation; conditioned and pelletized at controlled temperatures followed by sieving and bagging

    Final product types

    • Dairy cow and beef cattle medicated feed granules
    • Goat and sheep holistic herbal premix pellets
    • Intensive farmed livestock feed additives for improved digestion

    Free Quote

    Competitive Quisqualis Fructus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Quisqualis Fructus: Veterinary Grade API for Diverse Formulations

    Introduction

    Every season brings its own set of challenges in animal health and treatment. As the direct manufacturer of Quisqualis Fructus Veterinary Grade API, our team handles raw botanicals, extraction, purification, and drying here on-site, watching each batch transform from plant to potent ingredient. Veterinarians, feed mills, and animal healthcare formulators rely on consistent, dependable active pharmaceutical ingredients to ensure their products deliver the therapeutic performance animals count on. With Quisqualis Fructus, we set out to answer that call, building on years of expertise at every production step.

    What Sets Our API Apart

    Quisqualis Fructus, often recognized in herbal pharmacopeia for its contribution to animal digestive support and parasite control, goes through a rigorous selection before any further processing begins. Field agronomists inspect the fruit for maturity and phyto-composition. By investing in full traceability from field through final drying, we safeguard every lot for consistent active content and minimal contaminants. This matters, especially in veterinary APIs, since variability in plant material can impact the end product’s performance or safety.

    Many veterinary pharmaceutical makers are frustrated by inconsistent powder flow, unclear sourcing, or questions about heavy metal and solvent residues. These issues often trace back to shortcuts in upstream handling. Our own integrated process prevents those shortcuts. In our factory, dedicated extraction suites rely on food-grade solvents and monitored temperature controls. Technicians record every parameter, carefully adjusting as needed for fruit batch differences. This level of oversight has a direct effect on your finished tablets, injectables, and feed premixes.

    Grade-Driven Production Choices

    Veterinary formulations demand clear separation from human medicines, both in ingredient specification and traceable warehousing. Our Quisqualis Fructus API comes from pharmaceutical-grade raw fruit, processed separately from food or cosmetic lines. Clean-in-place systems and cross-checks between equipment batches reduce the risk of unintentional cross-contamination. For injectables, requirements for endotoxin levels surpass even the standards for oral forms. As a manufacturer, we alter our extraction protocols and drying endpoints specifically for injectable-grade orders—ensuring safe parenteral use. Our team understands how minor variations here influence a product’s finished appearance and reconstitution speed.

    On the feed supplement side, premixes and granules require different particle size distributions. Cheaper, generic APIs often clump and lead to “hot spots” or losses in even dispersion. Our dry milling and micro-sieving process results in a flowing, fine powder that works with automated filling and blending lines—helping you avoid frustrating cleanup stops and product recalls. Throughout, we routinely sample for particle size uniformity, microbial presence, and active marker compounds, using in-house HPLC and GC systems calibrated to pharmacopoeial standards.

    Model, Specifications, and Application

    Quisqualis Fructus API leaves our gates in formats tailored to the realities of large-batch manufacturing and compounding pharmacies. We offer the product as a highly purified, micro-milled powder (80-120 mesh), as well as intermediate granules for applications needing immediate dispersion. Moisture content stays controlled below 5%, reducing storage risks in humid climates or longer overseas shipments.

    Each lot certificate details assay ranges for key actives—such as quisqualic acid or flavonoid markers—matching your registration and regulatory filing requirements. In practice, we see most veterinary firms compressing tablets or encapsulating our powder directly, often without the need for extra excipients to achieve smooth flow. For liquid forms, we supply a filter-sterilized, injectable-grade concentrate, ready for aqueous suspension or further dilution. The stability profiles average over 24 months in cool, dry storage, giving you flexibility in inventory planning. For sensitive blends, our R&D team supports formula adaptation so you avoid loss of actives during high-heat processing.

    Animal health products aren’t just about isolated molecular action. Quality API unlocks measurable therapeutic benefits—visible in feed intake recovery, improved faecal scoring, or lower parasite loads in trial groups. Feedback from vet hospitals and field units confirms Quisqualis Fructus API’s utility in maintaining digestive comfort during high-stress periods or as part of a targeted deworming rotation. Unlike synthetic actives, our botanical-based ingredient brings a range of complementary compounds, adding resilience against resistance development.

    Differences from Commodity or Commercial-Grade Options

    Not every Quisqualis Fructus powder comes with the same assurance. We often review samples from outside traders and find inconsistent phytochemical signatures, heavy filler use, or worrisome solvent residues from lower-tier extraction plants. Cheaper “herbal” APIs rarely fit veterinary pharmacopoeial standards and can introduce variability (or outright adulteration) into critical treatments. Having full upstream control lets us avoid these pitfalls. Our internal QC lab rejects shipments that miss active content ranges, toxic element limits, or unapproved carrier presence.

    As both a grower partner and manufacturer, we bridge the gap between rural harvests and finished pharma-grade material. High transparency matters: purchasing managers frequently visit our facilities, reviewing batch records and historical compliance data. This trust and open-door approach help end-users sleep at night, knowing the source of every kilogram. Formulators using our Quisqualis Fructus report higher batch yields, reduced blending times, and fewer customer complaints after switching. Those are tangible operational gains—lower wastage, less equipment downtime, and fewer rejected finished packs.

    On the documentation front, we don’t leave our partners in the dark. Our certificates go beyond mere test results—providing full extraction solvent breakdown, pesticide screening, and cumulative batch data. For contract partners, live batch tracking integrates with ERP systems, enabling full forward and backward traceability. If a farmer or inspector ever flags a concern, we instantly pinpoint source, date, and batch context. This is a real-world guarantee—not a theoretical promise.

    Practical Use in Finished Forms

    Tablet makers notice smoother compression using our API—fewer hard spots, better hardness profiles, and reduced capping risk. Many customers share stories of how they finally reached robust low-dose formulations without moving to synthetic fillers. Feed millers find our free-flowing granules make for predictable dosing in automated lines. Injectable solution manufacturers benefit from our focus on low endotoxin and rapid dissolution specs, meaning batch release happens on schedule with high batch acceptance.

    Veterinary medicine has some unique field demands—insisting on both safety and performance across multiple species. Bird and ruminant applications sometimes call for ultra-fine sizing; our jet-milled material delivers that consistency. For companion animals, manufacturers need low-odour, neutral-tasting API to reduce palatability challenges. Each batch is taste-profiled and checked against species-specific palatability standards, so you avoid the “refusal to eat” issue that dooms so many new launches.

    Premix and solution blending partners often describe supply logistics as a key concern. With controlled packaging in lined drums and multi-layer bags, our API endures long hauls and warehouse transfers without degrading or absorbing off-odours. The packaging team regularly audits suppliers’ barrier material quality, pushing them to match our own handling demands. On arrival, customers report no caking, no formation of clumps, and active content still within original specification. That sort of reliability translates to fewer storage headaches and steady output in your plants.

    The Reality of Compliance and Documentation

    Navigating global veterinary regulations takes a mountain of paperwork, trusted lab relationships, and real-world know-how about country-level differences. As a primary producer, we deliver full GMP-compliant documentation, veterinarian-reviewed dossiers, and up-to-date safety profiles. Our regulatory team tracks health authority notices across importing markets, so partners stay in compliance—whether for a local regulatory audit or a multinational registration.

    International buyers turn to manufacturers with demonstrated transparency and quality consistency, not vague promises from trading middlemen. Our in-house chromatographers test every incoming botanical lot and supervise full-path tracking from harvest to outgoing batch. This means if a customer receives a rare “out of trend” result, both cause and corrective action can be investigated and explained, not waved away or delayed.

    Sterility, solvent residues, and heavy metals top the list of veterinary health risks. Our screening methods guard against out-of-spec events, but more importantly, we place preventative controls at the source. Farmers use only approved agro-chemicals. Drying schedules and extraction are set to minimize mycotoxin formation, a risk in many poorly controlled herbal APIs. Every product batch exits with an up-to-date safety data sheet, full compliance paperwork, and logged analytical trends, enabling your own QC and QA teams to close the regulatory loop with precision.

    End-to-End Customer Support and Adaptability

    API supply is a relationship business. Our technical service staff, trained in pharmacy and veterinary sciences, engage directly with customer labs—helping to resolve friction points from early formulation through to ongoing QC support. Some partners send us retain samples for side-by-side testing, knowing our lab handles real, scaled testing environments. We often help customers interpret international import rules, harmonize documents, or develop stability data for new blends using our API. This real-world support lets customers reduce risk on complex launches or country expansions. Batch recalls remain vanishingly rare, and most requests for analytic documentation are handled in forty-eight hours or less.

    Emerging trends in animal health keep everyone on their toes. Resistance management, demand for drug-free therapy options, supply chain resilience, and the push toward clean-label feed additives—all of these intersect with our daily manufacturing challenges. By keeping production in-house and maintaining direct grower relationships, we have avoided the supply shocks that have hurt several regions during unexpected climatic events or border closures.

    Field Learning and Innovation

    Innovation in botanical APIs does not stop at the extraction vat. Feedback from end-users—whether veterinary clinics, feedlot managers, or compounding pharmacists—often leads to incremental improvements in the process. Our most recent process improvements resulted from field complaints about dustiness in open-plan granule handling lines, which we fixed with gentle agglomeration and anti-static packaging changes. Likewise, stability at high summer temperatures drove the introduction of secondary barrier linings in packaging.

    We run annual farm trials, supporting both commercial and academic research partners. This hands-on approach gives us data on how various animal species respond in real barnyard conditions, not just in laboratory cages. These insights feed back into our technical dossiers and help future customers understand where Quisqualis Fructus fits dietary and therapeutic protocols. In some markets, we assist with post-market monitoring or follow-on studies, actively contributing to the broader base of animal health science.

    Looking Forward: Industry Requirements and Solutions

    Each formulation project brings its own needs. Small-scale compounding requires flexible, smaller pack sizes to minimize loss or degradation. Large feed mills require API lots with tight granule size control and robust certificates. As veterinary medicine responds to changing disease patterns or consumer demand, APIs must keep pace. New high-dose formats challenge stability, taste masking, and process flow; faster medicine release for acute field outbreaks tests both purity and solubility.

    Our solutions evolve accordingly. We invest in staff training for regulatory affairs as rules shift. Our plant engineering team keeps upgrading extraction and micronization for new solubility targets. Investment in analytics ensures our certificates reflect the evolving needs of both regulators and clinicians. Contract customers and research partners influence both process and form—so the final API delivered not only meets the current needs, but also anticipates tomorrow’s, with minimal transition risk.

    Conclusion

    Years of direct manufacturing teach us that real quality emerges from control and diligence—at every stage, from field agronomy through to drum packaging. By controlling every link in the chain, agricultural, mechanical, and analytical, we equip our partners to create safe, effective, and trusted animal health treatments. Quisqualis Fructus Veterinary Grade API, from our factory, brings assurance in every batch, and performance you can measure on the farm and in the clinic. We will keep listening, adjusting, and investing in quality—because the animals and the people who care for them deserve nothing less.

    Top